Medical Marijuana I Stock Performance
| MJNA Stock | USD 0.0004 0.0001 33.33% |
The company secures a Beta (Market Risk) of -0.42, which conveys possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Medical Marijuana are expected to decrease at a much lower rate. During the bear market, Medical Marijuana is likely to outperform the market. At this point, Medical Marijuana has a negative expected return of -0.76%. Please make sure to verify Medical Marijuana's skewness, day typical price, and the relationship between the maximum drawdown and daily balance of power , to decide if Medical Marijuana performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Medical Marijuana I has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors. ...more
| Total Cashflows From Investing Activities | -82.9 M |
Medical |
Medical Marijuana Relative Risk vs. Return Landscape
If you would invest 0.11 in Medical Marijuana I on September 26, 2024 and sell it today you would lose (0.07) from holding Medical Marijuana I or give up 63.64% of portfolio value over 90 days. Medical Marijuana I is currently does not generate positive expected returns and assumes 12.764% risk (volatility on return distribution) over the 90 days horizon. In different words, most equities are less risky than Medical, and most traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Medical Marijuana Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Medical Marijuana's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Medical Marijuana I, and traders can use it to determine the average amount a Medical Marijuana's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0594
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | MJNA |
Estimated Market Risk
| 12.76 actual daily | 96 96% of assets are less volatile |
Expected Return
| -0.76 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.06 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Medical Marijuana is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Medical Marijuana by adding Medical Marijuana to a well-diversified portfolio.
Medical Marijuana Fundamentals Growth
Medical Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Medical Marijuana, and Medical Marijuana fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Medical Pink Sheet performance.
| Return On Equity | 0.12 | |||
| Return On Asset | -0.0146 | |||
| Profit Margin | 0.15 % | |||
| Operating Margin | (0.04) % | |||
| Current Valuation | 62.53 M | |||
| Shares Outstanding | 3.44 B | |||
| Price To Earning | 5.25 X | |||
| Price To Book | 0.55 X | |||
| Price To Sales | 0.86 X | |||
| Revenue | 58.98 M | |||
| EBITDA | 1.45 M | |||
| Cash And Equivalents | 4.68 M | |||
| Total Debt | 10.41 M | |||
| Debt To Equity | 0.13 % | |||
| Book Value Per Share | 0.02 X | |||
| Cash Flow From Operations | 86.86 M | |||
| Earnings Per Share | 0 X | |||
| Total Asset | 209.53 M | |||
| Retained Earnings | 31.14 M | |||
| Current Asset | 14.02 M | |||
| Current Liabilities | 5.37 M | |||
About Medical Marijuana Performance
By analyzing Medical Marijuana's fundamental ratios, stakeholders can gain valuable insights into Medical Marijuana's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Medical Marijuana has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Medical Marijuana has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Medical Marijuana, Inc., an investment holding company, operates in the cannabinoid-based nutraceutical industry. Medical Marijuana, Inc. was incorporated in 2005 and is based in San Diego, California. Medical Marijuana operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 91 people.Things to note about Medical Marijuana performance evaluation
Checking the ongoing alerts about Medical Marijuana for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Medical Marijuana help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Medical Marijuana generated a negative expected return over the last 90 days | |
| Medical Marijuana has high historical volatility and very poor performance | |
| Medical Marijuana has some characteristics of a very speculative penny stock |
- Analyzing Medical Marijuana's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Medical Marijuana's stock is overvalued or undervalued compared to its peers.
- Examining Medical Marijuana's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Medical Marijuana's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Medical Marijuana's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Medical Marijuana's pink sheet. These opinions can provide insight into Medical Marijuana's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Medical Pink Sheet analysis
When running Medical Marijuana's price analysis, check to measure Medical Marijuana's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medical Marijuana is operating at the current time. Most of Medical Marijuana's value examination focuses on studying past and present price action to predict the probability of Medical Marijuana's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medical Marijuana's price. Additionally, you may evaluate how the addition of Medical Marijuana to your portfolios can decrease your overall portfolio volatility.
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes |